In short
- CVE-2019-15931 is a CRITICAL (CVSS 9.8) vulnerability affecting solismed (intesync).
- Chance of exploitation in the next 30 days (EPSS): 2.7%, higher than 86.1% of all vulnerabilities.
- No patched version is listed yet: follow the vendor's advisory in References.
| Package | Affected versions | Patched versions |
|---|
| solismed | = 3.3
| No fix yet |
Description
Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.
Running one of these products? Scan your site to see whether it exposes a vulnerable version.
Scan my site free